A Single Site, Open Label Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassemia
Latest Information Update: 04 Apr 2025
At a glance
- Drugs ET 01 (Primary)
- Indications Beta-thalassaemia
- Focus Adverse reactions
- Sponsors EdiGene Inc
Most Recent Events
- 30 Mar 2025 Status changed from active, no longer recruiting to discontinued.
- 06 Jun 2023 Status changed from recruiting to active, no longer recruiting.
- 17 Nov 2022 New trial record